Literature DB >> 10091101

Natural history of chronic hepatitis C.

L Pagliaro1, V Peri, C Linea, C Cammà, M Giunta, S Magrin.   

Abstract

BACKGROUND AND AIMS: A comprehensive overview on the course of hepatitis C is not available despite the many studies published. The aim was to review the course and prognostic variables of untreated hepatitis C.
METHODS: English-language articles published between January 1989 and December 1997 were identified and data extracted to answer predefined relevant questions.
RESULTS: Median chronicization rate, mostly assessed in transfusion-associated hepatitis, was 67%. In retrospective studies, the interval between date of infection and diagnosis of cirrhosis or hepatocellular carcinoma was 20-40 years. Median progression rate from chronic hepatitis to cirrhosis was 27.9% after 8-12 years. Studies obtaining this figure included selected groups of patients and could reflect the worst prognostic segment of the disease. The course of hepatitis C virus infection may be more favourable: cirrhosis rarely or never occurred in young females infected by con-taminated anti-D-immunglobulins; hepatitis was histologically mild in most hepatitis C virus-RNA positive subjects with normal or near normal transminases, predicting non-progressive or very slowly progressive disease; in a population survey from Italy, among 170 infected subjects only 4% had raised transaminases, and none overt liver disease. Increasing age, histological severity, alcohol, possibly male sex and liver iron content were predictors of cirrhosis or increased fibrosis.
CONCLUSIONS: Chronicization rate of hepatitis C virus infection is very high. Hepatitis C virus infection can result in a wide prognostic spectrum of liver disease, ranging from cirrhosis and hepatocellular carcinoma to subclinical, nonprogressive disease. Cofactors such as alcohol excess are important in determining the outcome of hepatitis C virus-related chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10091101

Source DB:  PubMed          Journal:  Ital J Gastroenterol Hepatol        ISSN: 1125-8055


  13 in total

1.  Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A.

Authors:  Yang Cheng; Sébastien Dharancy; Mathilde Malapel; Pierre Desreumaux
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 2.  Hepatitis C: cost of illness and considerations for the economic evaluation of antiviral therapies.

Authors:  John B Wong
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

3.  Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials.

Authors:  L L Kjaergard; K Krogsgaard; C Gluud
Journal:  BMJ       Date:  2001-11-17

Review 4.  Diffusion-weighted MRI of the liver: challenges and some solutions for the quantification of apparent diffusion coefficient and intravoxel incoherent motion.

Authors:  Yi Xiang J Wang; Hua Huang; Cun-Jing Zheng; Ben-Heng Xiao; Olivier Chevallier; Wei Wang
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-04-15

5.  Cost effectiveness of combination therapy for hepatitis C: a decision analytic model.

Authors:  K Stein; W Rosenberg; J Wong
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

6.  Prevalence of hepatitis C infection in a population of asymptomatic people in a checkup unit in Mexico city.

Authors:  Nahum Méndez-Sánchez; Guadalupe Ponciano-Rodriguez; Norberto C Chávez-Tapia; Daniel Motola-Kuba; Paloma Almeda-Valdes; Karla Sánchez-Lara; Martha H Ramos; Misael Uribe
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

7.  Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected non-responders and relapsers after interferon alfa-2a monotherapy.

Authors:  P Wietzkebetaraun; V Meier; F Braun; G Ramadori
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 8.  Female gender in the setting of liver transplantation.

Authors:  Kryssia Isabel Rodríguez-Castro; Eleonora De Martin; Martina Gambato; Silvia Lazzaro; Erica Villa; Patrizia Burra
Journal:  World J Transplant       Date:  2014-12-24

9.  High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy.

Authors:  Giovanni Squadrito; Marcello Previti; Marco Lenzi; Enrico Pagano Le Rose; Gaia Caccamo; Tea Restuccia; Enrico Di Cesare; Teresa Pollicino; Giovanni Raimondo
Journal:  Dig Dis Sci       Date:  2003-02       Impact factor: 3.199

10.  Alanine aminotransferase flare-up in hepatitis C virus carriers with persistently normal alanine aminotransferase levels in a hyperendemic area of Japan.

Authors:  Hirofumi Uto; Joji Kurogi; Yuka Takahama; Kazunori Kusumoto; Katsuhiro Hayashi; Akio Ido; Michinori Kohara; Sherri O Stuver; Akihiro Moriuchi; Susumu Hasegawa; Makoto Oketani; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.